This page contains information that is intended for residents of the United Kingdom only and is not meant to substitute for the advice provided by a medical professional. Always consult a healthcare professional if you have health concerns.
IBSA UK Products
REPORT ADVERSE EVENTS
If you get any side-effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side-effects, you can help provide more information on the safety of this medicine. To report a side effect or product complaint to IBSA Pharma please contact IBSA Pharma Ltd on 01923233466 and medicalinformation.uk@ibsagroup.com
Fostimon® (Urofollitropin)
SmPC
Meriofert® (Menotrophin) 75 IU/150 IU
SmPC
Meriofert® (Menotrophin) 900 IU
SmPC
Lubion® (Progesterone)
SmPC
Zivafert▼(human Chorionic Gonadotrophin)
SmPC
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See Yellow Card | Making medicines and medical devices safer (mhra.gov.uk) for how to report side effects.